Study tests best way to warn young adults about vaping dangers
NCT ID NCT06274723
First seen Jan 17, 2026 · Last updated Jun 20, 2026 · Updated 19 times
Summary
This study looked at how to present e-cigarette education messages to young adults ages 18-24 who vape or are at risk of starting. Researchers tested different message sources (expert vs. peer) and presentation styles (one-sided vs. two-sided) to see which was most accepted and increased harm perceptions. The goal is to improve public health messaging around vaping.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAPING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UMass Chan Medical School
Worcester, Massachusetts, 01605, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help design more effective public health messages to reduce vaping among young adults.
What could go wrong
This is a completed crowdsourcing study, not a clinical treatment trial. Results may not apply to real-world settings or all populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.